DE60222812D1 - In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen - Google Patents

In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen

Info

Publication number
DE60222812D1
DE60222812D1 DE60222812T DE60222812T DE60222812D1 DE 60222812 D1 DE60222812 D1 DE 60222812D1 DE 60222812 T DE60222812 T DE 60222812T DE 60222812 T DE60222812 T DE 60222812T DE 60222812 D1 DE60222812 D1 DE 60222812D1
Authority
DE
Germany
Prior art keywords
repetitive
bacteria
proteins
big
similar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60222812T
Other languages
English (en)
Other versions
DE60222812T2 (de
Inventor
Albert I Ko
Reis Mitermayer Galvao
Croda Julio H Rosa
Isadora C Siqueira
David A Haake
James Matsunaga
Lee W Riley
Michele Barocchi
Tracy A Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacao Oswaldo Cruz
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/147,299 external-priority patent/US20040058323A1/en
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Application granted granted Critical
Publication of DE60222812D1 publication Critical patent/DE60222812D1/de
Publication of DE60222812T2 publication Critical patent/DE60222812T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
DE60222812T 2002-05-17 2002-05-20 In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen Expired - Lifetime DE60222812T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/147,299 US20040058323A1 (en) 2002-05-17 2002-05-17 Proteins with repetitive bacterial-Ig-like (big) domains present in leptospira species
US147299 2002-05-17
PCT/BR2002/000072 WO2003098214A1 (en) 2002-05-17 2002-05-20 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species

Publications (2)

Publication Number Publication Date
DE60222812D1 true DE60222812D1 (de) 2007-11-15
DE60222812T2 DE60222812T2 (de) 2008-08-28

Family

ID=34195214

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60222812T Expired - Lifetime DE60222812T2 (de) 2002-05-17 2002-05-20 In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen

Country Status (5)

Country Link
EP (1) EP1514104B1 (de)
AU (1) AU2002308453B2 (de)
CA (1) CA2486345C (de)
DE (1) DE60222812T2 (de)
WO (1) WO2003098214A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2501939C (en) 2002-10-10 2013-10-08 Cornell Research Foundation, Inc. Novel immunogenic proteins of leptospira
US20050089533A1 (en) * 2003-01-29 2005-04-28 Joseph Frantz Canine vaccines against Bordetella bronchiseptica
BRPI0505529A (pt) 2005-12-19 2007-09-25 Fundacao Oswaldo Cruz proteìnas liga e ligb (leptospiral ig-like(lig) domains) para vacinação e diagnóstico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091301A (en) * 1989-03-22 1992-02-25 The Unites States Of America As Represented By The Secretary Of Agriculture Diagnostic and epidemiological nucleic acid probe for bovine leptospirosis
IL121820A0 (en) * 1996-01-22 1998-02-22 Univ California Leptospiral outer membrane proteins

Also Published As

Publication number Publication date
EP1514104A1 (de) 2005-03-16
DE60222812T2 (de) 2008-08-28
AU2002308453B2 (en) 2009-12-03
WO2003098214A1 (en) 2003-11-27
CA2486345A1 (en) 2003-11-27
EP1514104A4 (de) 2005-12-07
EP1514104B1 (de) 2007-10-03
CA2486345C (en) 2012-08-14
AU2002308453A1 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
DK1495128T3 (da) Forstærket proteinekspression i Bacillus
IL228034A0 (en) Formulations with a high concentration of antibodies and proteins
SE0001826D0 (sv) Method in connection with engine control
DK1576170T3 (da) Nukleinsyrer og tilsvarende proteiner med betegnelsen 191p4d12(b), der kan anvendes i behandling og påvisning af cancer
DK1699821T3 (da) Fc-ERYTHROPOIETIN-FUSIONSPROTEIN MED FORBEDREDE FARMAKOKINETIKKER
NO20043564L (no) Follistatindomene som inneholder proteiner
IS7672A (is) Bóluefni gegn öldrunar- og æxlunarkerfa sýkingum í nautgripum
FI20021144A (fi) Menetelmä suuntaajasiltojen yhteydessä
IS8308A (is) Amínósýrur með sækni fyrir a2o prótíninu
DE60105696D1 (de) Eisenhaltige Proteinzusammensetzung
NO20031251D0 (no) Fremgangsmåte for fremstilling av små soyabaserte måltid med lavt fett- oghöyt proteininnhold
FI20010557A0 (fi) Menetelmä vaihtosuuntaajan yhteydessä
NO20025252L (no) Hydrofon med automatisk utkopling i tilfelle en justerbar neddykkingsgrenseoverskrides
DE60222812D1 (de) In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen
ATE374943T1 (de) In leptospira-spezies vorhandene proteine mit repetitiven bakterien-ig-ähnlichen (big-) domänen
FI20001004A0 (fi) Sovitelma taajuusmuuttajassa
ATE473002T1 (de) Zusammensetzungen zur vorbeugung von geschwüren in pferden
NO20053512D0 (no) IL-8-liknende proteiner
AU2003284952A1 (en) Serial sample injection in capillary electrophoresis
NO20052608D0 (no) Midkinlignende protein
EP1541677A4 (de) Neue proteine und verwendung davon
AU2003265635A8 (en) Nphp nucleic acids and proteins
SE0001979D0 (sv) Protein and method using said protein
FI20011705A0 (fi) Luun morfogeneettisiä proteiineja
NO20023809D0 (no) Magnetsåle for bruk i forbindelse med hestesko

Legal Events

Date Code Title Description
8381 Inventor (new situation)

Inventor name: KO, ALBERT I., CEP-40295-001 SALVADOR, BA, BR

Inventor name: GALVAO REIS, MITERMAYER, CEP-40295-001 SALVADO, BR

Inventor name: ROSA CRODA, JULIO H., CEP-40295-001 SALVADOR, , BR

Inventor name: SIQUEIRA, ISADORA C., CEP-40295-001 SALVADOR, , BR

Inventor name: HAAKE, DAVID A., LOS ANGELES, CA, US

Inventor name: MATSUNAGA, JAMES, LOS ANGELES, CA, US

Inventor name: RILEY, LEE W., BERKELEY, CA 94720, US

Inventor name: BAROCCHI, MICHELE, LOS ANGELES, US

Inventor name: YOUNG, TRACY A., BERKELEY, CA 94720, US

8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1514104

Country of ref document: EP

Representative=s name: FRITZ & BRANDENBURG PATENTANWAELTE, 50933 KOELN, D